FTXH First Trust Nasdaq Pharmaceuticals ETF
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| FTXH | +6.7% | +10.8% | +34.4% | +41.0% | +23.4% | +11.7% |
| Sector Equity average (81 funds) | -1.2% | -4.5% | +13.3% | +15.0% | +17.1% | +6.1% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: −$211K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly and Company | 8.26% |
| 2 | ABBV AbbVie Inc. | 7.65% |
| 3 | JNJ Johnson & Johnson | 7.01% |
| 4 | PFE Pfizer Inc. | 6.88% |
| 5 | MRK Merck & Co., Inc. | 6.62% |
| 6 | VTRS Viatris Inc. | 4.24% |
| 7 | REGN Regeneron Pharmaceuticals, Inc. | 3.99% |
| 8 | BIIB Biogen Inc. | 3.89% |
| 9 | GILD Gilead Sciences, Inc. | 3.86% |
| 10 | AMGN Amgen Inc. | 3.62% |
| 11 | ZTS Zoetis Inc. | 3.56% |
| 12 | UTHR United Therapeutics Corporation | 3.44% |
| 13 | VRTX Vertex Pharmaceuticals Incorporated | 3.34% |
| 14 | INCY Incyte Corporation | 3.26% |
| 15 | BMY Bristol-Myers Squibb Company | 3.13% |
| 16 | JAZZ Jazz Pharmaceuticals Plc | 2.62% |
| 17 | EXEL Exelixis, Inc. | 2.62% |
| 18 | ILMN Illumina, Inc. | 1.64% |
| 19 | MEDP Medpace Holdings, Inc. | 1.52% |
| 20 | NBIX Neurocrine Biosciences, Inc. | 1.37% |
| 21 | HALO Halozyme Therapeutics, Inc. | 1.36% |
| 22 | ELAN Elanco Animal Health Incorporated | 1.26% |
| 23 | BMRN BioMarin Pharmaceutical Inc. | 1.14% |
| 24 | CRL Charles River Laboratories International, Inc. | 1.10% |
| 25 | MRNA Moderna, Inc. | 0.82% |
| 26 | ALNY Alnylam Pharmaceuticals, Inc. | 0.76% |
| 27 | AMRX Amneal Pharmaceuticals, Inc. | 0.57% |
| 28 | TGTX TG Therapeutics, Inc. | 0.56% |
| 29 | ROIV Roivant Sciences Ltd. | 0.56% |
| 30 | ADPT Adaptive Biotechnologies Corporation | 0.56% |
| 31 | SYRE Spyre Therapeutics, Inc. | 0.55% |
| 32 | ORKA Oruka Therapeutics, Inc. | 0.53% |
| 33 | KYMR Kymera Therapeutics, Inc. | 0.52% |
| 34 | TNGX Tango Therapeutics, Inc. | 0.52% |
| 35 | LGND Ligand Pharmaceuticals Inc. (Class B) | 0.52% |
| 36 | ALKS Alkermes Plc | 0.47% |
| 37 | TXG 10X Genomics, Inc. (Class A) | 0.46% |
| 38 | IOVA Iovance Biotherapeutics, Inc. | 0.46% |
| 39 | GH Guardant Health, Inc. | 0.45% |
| 40 | CAI Caris Life Sciences, Inc. | 0.44% |
| 41 | PTGX Protagonist Therapeutics, Inc. | 0.42% |
| 42 | ELVN Enliven Therapeutics Inc. | 0.41% |
| 43 | TWST Twist Bioscience Corporation | 0.41% |
| 44 | KRYS Krystal Biotech, Inc. | 0.40% |
| 45 | DNTH Dianthus Therapeutics, Inc. | 0.39% |
| 46 | LQDA Liquidia Technologies, Inc. | 0.37% |
| 47 | TVTX Travere Therapeutics, Inc. | 0.36% |
| 48 | CORT Corcept Therapeutics Inc. | 0.30% |
| 49 | ACAD ACADIA Pharmaceuticals Inc. | 0.29% |
| 50 | ARWR Arrowhead Pharmaceuticals, Inc. | 0.28% |
| 51 | FTXH US Dollar | 0.21% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Sep 24, 2026 | $0.0113 |
| Jun 25, 2026 | $0.0920 |
| Mar 26, 2026 | $0.0573 |
| Dec 12, 2025 | $0.1294 |
| Sep 25, 2025 | $0.1453 |
| Jun 26, 2025 | $0.0892 |
| Mar 27, 2025 | $0.0992 |
| Dec 13, 2024 | $0.1304 |
| Sep 26, 2024 | $0.1218 |
| Jun 27, 2024 | $0.1284 |
| Mar 21, 2024 | $0.0676 |
| Dec 22, 2023 | $0.1232 |
| Sep 22, 2023 | $0.0725 |
| Jun 27, 2023 | $0.1179 |
| Mar 24, 2023 | $0.1001 |
| Dec 23, 2022 | $0.1253 |
| Sep 23, 2022 | $0.0911 |
| Jun 24, 2022 | $0.0384 |
| Mar 25, 2022 | $0.0488 |
| Dec 23, 2021 | $0.1101 |
| Sep 23, 2021 | $0.0393 |
| Jun 24, 2021 | $0.0533 |
| Mar 25, 2021 | $0.0771 |
| Dec 24, 2020 | $0.0644 |
| Sep 24, 2020 | $0.0428 |
| Jun 25, 2020 | $0.0463 |
| Mar 26, 2020 | $0.0591 |
| Dec 13, 2019 | $0.0411 |
| Sep 25, 2019 | $0.0501 |
| Jun 14, 2019 | $0.0395 |
| Mar 21, 2019 | $0.0260 |
| Dec 18, 2018 | $0.0367 |
| Sep 14, 2018 | $0.0256 |
| Jun 21, 2018 | $0.0354 |
| Mar 22, 2018 | $0.0776 |
| Sep 21, 2017 | $0.3801 |
| Jun 22, 2017 | $0.0553 |
| Mar 23, 2017 | $0.0313 |
| Dec 21, 2016 | $0.0340 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in FTXH in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error